Clinic
Amana Medical Care, INC.
Amana Medical Care, INC. was paid $2.39M by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoAMANA MEDICAL CARE, INC.
DAVENPORT, IA 52806
DAVENPORT, IA 52806
33aNPI1306235072assigned 01/17/2015
33bProvider typeUrgent Care Clinic/Center
28Total paid$2.39M
24GClaims59,019
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Iowa
Rank by total paid#1 of 9
Median peer was paid$138K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,868 | $159K | |
| 2019 | 7,338 | $236K | |
| 2020 | 6,878 | $259K | |
| 2021 | 10,222 | $429K | |
| 2022 | 11,902 | $532K | |
| 2023 | 10,084 | $398K | |
| 2024incomplete | 7,727 | $374K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 19,193 | 17,561 | $636K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 19% | 7,154 | 6,950 | $446K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17% | 8,746 | 8,166 | $404K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 13% | 8,172 | 7,642 | $312K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 12% | 3,293 | 3,053 | $280K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.8% | 3,793 | 3,511 | $187K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.6% | 440 | 420 | $39K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,686 | 1,617 | $24K |
| 87634 | <1% | 241 | 221 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,086 | 521 | $15K |
| H0033 | Oral medication administration, direct observation | <1% | 448 | 419 | $8K |
| 87631 | <1% | 54 | 54 | $6K |
14 more codes
| 81002 | <1% | 2,270 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 245 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 152 | $3K |
| 99000 | <1% | 1,036 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 14 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 284 | $857.69 |
| 36415 | Collection of venous blood by venipuncture | <1% | 284 | $715.40 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 29 | $684.62 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 71 | $307.65 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 77 | $47.70 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 31 | $46.49 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 15 | $5.85 |
| 99072 | 0% | 135 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 70 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOTOB, MOUTAZ (SECRETARY)